Contrasting time- and rate-based approaches for the assessment of drug-induced QT changes

被引:10
作者
Extramiana, Fabrice
Badilini, Fabio
Sarapa, Nenad
Leenhardt, Antoine
Maison-Blanche, Pierre
机构
[1] Univ Paris 07, Dept Cardiol, APHP, Lariboisiere Univ Hosp, F-75010 Paris, France
[2] AMPS LLC, New York, NY USA
[3] Daiichi Sankyo Pharma Dev, Edison, NJ USA
关键词
QT interval; sotalol; Holter ECG;
D O I
10.1177/0091270007302953
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The authors aim to highlight the pitfalls of different validated methods used for the assessment of drugs' effect on QT duration. Digital 12-lead Holter electrocardiograms were recorded at baseline and after a single dose of sotalol in 39 healthy-subjects (age =27.4 +/- 8.0 years). Using both time-and rate-based approaches, the authors obtained averaged QRS-T complexes every minute ("time bins") and at different RR intervals ("rate bins"). Time bins were corrected for heart rate using a subject-specific approach, The individual a coefficients increased from placebo (0.309 +/- 0.052) to sotalol (0.454 +/- 0.136), P < .0001. When the placebo individual a coefficients were applied to correct the QT interval on sotalol, the changes were > 5 ms smaller than those obtained using the ON drug a coefficients. The "rate"-averaging process leads to a complete loss of the time course of drug effect. In conclusion, the individual correction formula calculated from the placebo condition cannot always be used for QT correction on the drug.
引用
收藏
页码:1129 / 1137
页数:9
相关论文
共 38 条
[1]   QT interval analysis on ambulatory electrocardiogram recordings: a selective beat averaging approach [J].
Badilini, F ;
Maison-Blanche, P ;
Childers, R ;
Coumel, P .
MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 1999, 37 (01) :71-79
[2]  
BADILINI F, 2004, CARDIAC SAFETY NONCA
[3]  
Bazett HC, 1920, HEART-J STUD CIRC, V7, P353
[4]  
BEXTON RS, 1986, BRIT HEART J, V55, P253
[5]   PROLONGATION OF THE Q-T INTERVAL IN MAN DURING SLEEP [J].
BROWNE, KF ;
PRYSTOWSKY, E ;
HEGER, JJ ;
CHILSON, DA ;
ZIPES, DP .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (01) :55-59
[6]   Assessment of the stability of the individual-based correction of QT interval for heart rate [J].
Couderc, JP ;
Xia, XJ ;
Zareba, W ;
Moss, AJ .
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2005, 10 (01) :25-34
[7]   Clinical relevance and management of drug-related QT interval prolongation [J].
Crouch, MA ;
Limon, L ;
Cassano, AT .
PHARMACOTHERAPY, 2003, 23 (07) :881-908
[8]   Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients [J].
Curtis, LH ;
Ostbye, T ;
Sendersky, V ;
Hutchison, S ;
Lapointe, NMA ;
Al-Khatib, SM ;
Yasuda, SU ;
Dans, PE ;
Wright, A ;
Califf, RM ;
Woosley, RL ;
Schulman, KA .
AMERICAN JOURNAL OF MEDICINE, 2003, 114 (02) :135-141
[9]   Individual QT-R-R relationship: Average stability over time does not rule out an individual residual variability: Implication for the assessment of drug effect on the QT interval [J].
Extramiana, F ;
Maison-Blanche, P ;
Badilini, F ;
Beaufils, P ;
Leenhardt, A .
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2005, 10 (02) :169-178
[10]   Clinical assessment of drug-induced QT prolongation in association with heart rate changes [J].
Extramiana, F ;
Maison-Blanche, P ;
Cabanis, M ;
Ortemann-Renon, C ;
Beaufils, P ;
Leenhardt, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (04) :247-258